BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/DSTYK/Compounds

Compounds That Target DSTYK

dual serine/threonine and tyrosine protein kinase · 15 compounds in BiohacksAI corpus

DSTYK (dual serine/threonine and tyrosine protein kinase) is a biological target with 15 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into DSTYK modulation for therapeutic and biohacking applications.

View DSTYK target page →UniProt: Q6XUX3 ↗
Most Studied Compounds for DSTYK
1
Crizotinib
298+
studies
All 15 Compounds — Ranked by Evidence
1
Alvocidib
4.52
confidence
2
Foretinib
4.34
confidence
3
Bosutinib
4.08
confidence
4
Midostaurin
3.85
confidence
5
Neratinib
3.66
confidence
6
Tae 684
3.43
confidence
7
Fedratinib
3.40
confidence
8
Dabrafenib
3.30
confidence
9
Lestaurtinib
3.04
confidence
10
Defosbarasertib
2.89
confidence
11
Kw 2449
2.64
confidence
12
Ast 487
2.56
confidence
13
Su 014813
2.20
confidence
14
Rg 547
2.08
confidence
15
Crizotinib
298+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for DSTYK (dual serine/threonine and tyrosine protein kinase). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: DSTYK target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.